CORDIS Project

Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life

SERENITY·101057292·HORIZON

Funding breakdown and partner intelligence are Premium

Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1

Upgrade

Start free • Cancel anytime • 14-day refund guarantee

View on CORDIS DOI grant

Funding data

Programme: Horizon Europe
Participants: 4
Start - End: 01/10/2022 — 30/09/2027
Status: SIGNED

Summary

SERENITY aims to improve decision-making around antithrombotic therapy for cancer patients nearing the end of life by developing a web-based shared decision support tool. This tool will consider individual patient factors to enhance treatment appropriateness, reduce complications, and improve quality of life.

Objective

Despite the fact that antithrombotic therapy (ATT) has little or even negative effects on the well-being of cancer patients during their last year of life, stopping ATT is rare in clinical practice.

In contrast, ATT is often continued until death, resulting in excess bleeding, higher healthcare costs, and increased disease burden. SERENITY will develop an information-driven, palliative care shared decision-making process enabled by a user-friendly, easily accessible, web-based shared decision su…

Full objective and premium intelligence

Upgrade to Premium for the complete objective, AI summary, similar projects, consortium analytics, OpenAlex context, and funding breakdown.

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Coordinator

Leiden University Medical Center

ACADEMISCH ZIEKENHUIS LEIDEN

Country: Netherlands, Leiden
Organization type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No

Network and participants(4 participants)

Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.

CHU SAINT-ETIENNE
France, Saint Etienne
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
participant
UMC UTRECHT
Netherlands, Utrecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant
UMC-Mainz
Germany, Mainz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
France, Paris
Type: Research institute
Activity type: Research Organisations
SME: No
participant

4 participants shown of 15

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Partner & research intelligence

Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.

Consortium analytics and research context are Premium

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

CORDIS call / funding scheme

Programme: HORIZON
Call: HORIZON-HLTH-2021-DISEASE-04
Sub call: HORIZON-HLTH-2021-DISEASE-04
Funding scheme: HORIZON-RIA
Domain note: This block describes the CORDIS project call context. Live open opportunities are managed in the Funding & Tenders domain.

Fields of Science (EuroSciVoc)

Guests see up to 5 EuroSciVoc fields.

Medical and health sciencesClinical medicineOncology

Topic

Guests see up to 5 topics.

HORIZON-HLTH-2021-DISEASE-04-01

Sector

Guests see up to 5 sectors.

Health & Biotech

Keywords

Guests see up to 5 keywords.

antithrombotic therapy thrombosis cancer palliative care patient empowerment